Press Release

VIENNA – September 3, 2012 – Vertex Pharmaceuticals Incorporated today presented results from the KALYDECO™ (ivacaftor) clinical trials programme at the European Respiratory Society (ERS) congress in Vienna.

Powered by WPeMatico